Diclofenac Sodium Tablet, Delayed Release shortage
Diclofenac Sodium Tablet, Delayed Release is currently listed in shortage by the FDA. The FDA lists 6 affected products. This page was last refreshed from FDA data on Sep 17, 2026.
Teva is permanently stopping its diclofenac sodium delayed-release tablets (a pain and inflammation medicine), and no supply remains from Teva. Other makers — including Rising Pharma, AvKARE, Edenbridge, and PD-Rx — still list the 25 mg, 50 mg, and 75 mg strengths as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Diclofenac Sodium Tablet, Delayed Release. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Aug 13, 2026Currently in shortage6 of 6 products affected.
-
Aug 13, 2026First reported to the FDA6 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-06) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-11) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-96) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-11) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-96) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Diclofenac Sodium Tablet, Delayed Release — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Diclofenac Sodium Tablet, Delayed Release? options further down this page.
Why is Diclofenac Sodium Tablet, Delayed Release in shortage?
Teva Pharmaceuticals has made a business decision to permanently stop making their versions of diclofenac sodium delayed-release tablets — both the 50 mg and 75 mg strengths, across all of their package sizes. No specific reason beyond "a business decision" was shared publicly, so unfortunately there's no more detail available about what drove that choice.
It's worth knowing that this report only covers Teva's products. It doesn't mean every manufacturer has stopped making this medication — other companies may still produce it and are listed separately.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Diclofenac Sodium Tablet, Delayed Release, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Diclofenac Sodium Tablet, Delayed Release?
Diclofenac sodium delayed-release tablets are currently on the FDA shortage list. This affects both the 50 mg and 75 mg strengths. According to the report, there is no available source right now for either strength from the manufacturer that filed it (Teva), and both are listed as "to be discontinued."
The reported reason is a business decision by that manufacturer to stop making the drug. Because this is a discontinuation rather than a temporary delay, this particular supply may not return. That said, this report reflects only one manufacturer — other companies still make the same medicine, so it is not gone everywhere.
Here is what I suggest:
- Do not stop, skip, or change how you take your diclofenac on your own.
- Because your exact strength is being discontinued by this maker, ask your pharmacy whether they can source the same medicine — diclofenac sodium delayed-release 50 mg or 75 mg — from another manufacturer. Options in our records include Rising Pharma, AvKARE, and Golden State Medical Supply, among others. These may not be in local stock, but your pharmacy can check wholesalers.
- If your strength cannot be found, ask your prescriber or pharmacist about next steps, such as a clinician-chosen alternative.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls.
This is general, national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Diclofenac Sodium Tablet, Delayed Release?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Diclofenac Sodium Tablet, Delayed Release is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Diclofenac Sodium | DICLOFENAC SODIUM 75 mg/1 | Tablet, Delayed Release · Oral | Rising Pharma Holdings, Inc. | 16571-0201-06 |
| Diclofenac Sodium | DICLOFENAC SODIUM 50 mg/1 | Tablet, Delayed Release · Oral | Rising Pharma Holdings, Inc. | 16571-0202-06 |
| Diclofenac Sodium | DICLOFENAC SODIUM 25 mg/1 | Tablet, Delayed Release · Oral | Rising Pharma Holdings, Inc. | 16571-0203-03 |
| Diclofenac Sodium | DICLOFENAC SODIUM 50 mg/1 | Tablet, Delayed Release · Oral | AvKARE | 42291-0230-10 |
| Diclofenac Sodium | DICLOFENAC SODIUM 75 mg/1 | Tablet, Delayed Release · Oral | AvKARE | 42291-0231-10 |
| Diclofenac Sodium | DICLOFENAC SODIUM 100 mg/1 | Tablet, Extended Release · Oral | Edenbridge Pharmaceuticals LLC. | 42799-0953-01 |
| Diclofenac Sodium | DICLOFENAC SODIUM 50 mg/1 | Tablet, Delayed Release · Oral | PD-Rx Pharmaceuticals, Inc. | 43063-0467-14 |
| Diclofenac Sodium | DICLOFENAC SODIUM 50 mg/1 | Tablet, Delayed Release · Oral | A-S Medication Solutions | 50090-0538-00 |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM 75 mg/1 | Tablet, Delayed Release · Oral | A-S Medication Solutions | 50090-0545-00 |
| Diclofenac Sodium | DICLOFENAC SODIUM 100 mg/1 | Tablet, Film Coated · Oral | Ingenus Pharmaceuticals, LLC | 50742-0278-01 |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM 25 mg/1 | Tablet, Delayed Release · Oral | Golden State Medical Supply, Inc. | 51407-0536-01 |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM 50 mg/1 | Tablet, Delayed Release · Oral | Golden State Medical Supply, Inc. | 51407-0537-01 |
Alternative dosage forms of Diclofenac Sodium Tablet, Delayed Release
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Diclofenac Sodium 50 mg | Actavis | 1000 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium 50 mg | Rising | 60 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium 50 mg | Aurobindo | 100 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium 50 mg | American | 1 tablet | $0.062 | AB | Availability likely |
| Diclofenac Sodium Delayed Release 50 mg | Carlsbad | 100 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium Delayed Release 50 mg | Carlsbad | 100 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium 50 mg | BluePoint | 100 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium 50 mg | NorthStar | 1000 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium 50 mg | Advagen | 1000 tablets | $0.062 | AB | Availability likely |
| Diclofenac Sodium 75 mg | Actavis | 60 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | Rising | 60 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | Aurobindo | 100 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | American | 1 tablet | $0.064 | AB | Availability likely |
| Diclofenac Sodium Delayed Release 75 mg | Carlsbad | 100 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium Delayed Release 75 mg | Carlsbad | 100 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | BluePoint | 100 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | SOLA | 60 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | NorthStar | 60 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | Advagen | 1000 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | Actavis | 100 tablets | $0.064 | AB | Availability likely |
| Diclofenac Sodium 75 mg | Quality | 20 tablets | — | AB | Discontinued |
| Diclofenac Sodium 75 mg | AvKARE | 1000 tablets | — | AB | FDA listed |
| Diclofenac Sodium Delayed Release 75 mg | A-S | 100 tablets | — | AB | FDA listed |
| Diclofenac Sodium 75 mg | A-S | 90 tablets | — | AB | FDA listed |
| Diclofenac Sodium 75 mg | A-S | 100 tablets | — | AB | FDA listed |
| Diclofenac Sodium 75 mg | A-S | 90 tablets | — | AB | FDA listed |
| Diclofenac Sodium Delayed Release 75 mg | A-S | 90 tablets | — | AB | FDA listed |
| Diclofenac Sodium Delayed Release 75 mg | A-S | 100 tablets | — | AB | FDA listed |
| Diclofenac Sodium Delayed Release 75 mg | A-S | 90 tablets | — | AB | FDA listed |
| Diclofenac Sodium 75 mg | A-S | 100 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Diclofenac Sodium Tablet, Delayed Release — that fall in the same broad treatment class (nsaids, cyclooxygenase inhibitor type analgesics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Diclofenac Sodium Tablet, Delayed Release shortage FAQs
Is Diclofenac Sodium Tablet, Delayed Release in shortage?
Which products are affected?
When will Diclofenac Sodium Tablet, Delayed Release be available again?
Can I still get Diclofenac Sodium Tablet, Delayed Release somewhere?
What should I do if I take Diclofenac Sodium Tablet, Delayed Release?
Still have a question about the Diclofenac Sodium Tablet, Delayed Release shortage?
Ask a pharmacist about this shortage →View Diclofenac Sodium Tablet, Delayed Releas... on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.